Approvals/CIMA-AEMPS/PADCEV 30 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

PADCEV 30 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Astellas Pharma Europe B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 1c5e7b17b9b4b55a
Drug Cima Aemps Name: PADCEV 30 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1211615002IP
Holder Company Name: Astellas Pharma Europe B.V.
Marketing Company Name: Melyfarma S.L.
Holder Company Detail Path: /organization/astellas-pharma-europe-b-v
Authorization Date: 2024-04-04
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 30 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Astellas Pharma Europe B.V.
Company Detail Path: /organization/astellas-pharma-europe-b-v

ENFORTUMAB VEDOTINA

30 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 4, 2024

Approval ID

1c5e7b17b9b4b55a

Type

Standard